• Users Online: 593
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2021  |  Volume : 18  |  Issue : 3  |  Page : 184-186

Mucormycosis and COVID 19: From the desk of a periodontist


Department of Periodontics, Institute of Dental Sciences, Jammu, Jammu and Kashmir, India

Correspondence Address:
Malvika Singh
Department of Periodontics, Institute of Dental Sciences, Jammu, Jammu and Kashmir
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/am.am_54_21

Rights and Permissions

Oral mucormycosis is not a new disease and is known to occur in patients with low immunity such as in uncontrolled diabetes, posttransplant, and some cancer treatments. A sudden surge has been reported in mucormycosis in cases with COVID-19. Although rare, serious complication of COVID-19. The aim of this article is to discuss the periodontal presentation of oral mucormycosis in patients who currently have or have recovered from COVID-19 infection. Although fatal sometime, its successful treatment lies in the early diagnosis and for periodontists are the first doctors to identify the same, they should remain vigilant in its diagnosis so that the same can be treated by a multidisciplinary medical approach and fatalities can be avoided.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed590    
    Printed20    
    Emailed0    
    PDF Downloaded47    
    Comments [Add]    

Recommend this journal